SEOM clinical guideline on hereditary colorectal cancer (2019)

C. Guillén-Ponce, E. Lastra, I. Lorenzo-Lorenzo, T. Martín Gómez, R. Morales Chamorro, A. B. Sánchez-Heras, R. Serrano, M. C. Soriano Rodríguez, J. L. Soto, L. Robles

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

3 Citas (Scopus)

Resumen

In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.

Idioma originalInglés
Páginas (desde-hasta)201-212
Número de páginas12
PublicaciónClinical and Translational Oncology
Volumen22
N.º2
DOI
EstadoPublicada - 1 feb 2020

Nota bibliográfica

Publisher Copyright:
© 2020, The Author(s).

Huella

Profundice en los temas de investigación de 'SEOM clinical guideline on hereditary colorectal cancer (2019)'. En conjunto forman una huella única.

Citar esto